Navigation Links
Misonix Reports Fourth Quarter and Fiscal Year 2009 Financial Results
Date:10/1/2009

cted by a reduction in medical device products revenues by $902,000 to $5.5 million, partially offset by an increase in Laboratory and Scientific products revenues of $811,000 to $4.9 million. The decrease in medical device products revenue is primarily due to lower sales of ultrasonic probe repairs, MRI repair, replacement probes and our AutoSonix® product to Covidien. The increase in sales of Laboratory and Scientific products was primarily due to an increase in sales at Labcaire for ISIS product and service.

The Company reported a net loss for the fourth quarter ended June 30, 2009 from continuing operations of $804,000 or $.11 per share compared to a loss from continuing operations of $2.4 million or $.35 per share for the three months ended June 30, 2008. During the fourth fiscal quarter 2009, the Company sold its Ultrasonic Laboratory Products business to a subsidiary of Sonics and Materials Inc. for $3.5 million and reported an after tax gain of $2.7 million on the sale. The Company reported net income including the income and the gain on sale from discontinued operations of $2.2 million or $0.31 income per diluted share for the three months ended June 30, 2009 as compared to a loss of $2.4 million or $0.34 per diluted share.

Revenues for the twelve months ended June 30, 2009 were $39.8 million compared to revenues of $41.1 million for the twelve months ended June 30, 2008. Medical device products revenues were $22.8 million as of June 30, 2009, a decrease of $1.5 million from the same period in fiscal 2008. Laboratory and Scientific products revenues were $17.0 million, an increase of $161,000 from the same period in fiscal 2008.

Net income was $2.8 million or $.40 income per diluted share compared to a net loss of $2.9 million or $.41 per diluted share, which included income and the gain on sale from discontinued operations of $3.4 million and $536,000 for the periods ended June 30, 2009 and 2008, respectively. <
'/>"/>

SOURCE Misonix, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine technology :

1. Misonix Schedules Fourth Quarter and Fiscal Year 2009 Financial Results Conference Call; October 1, 2009 at 4:30 p.m. Eastern
2. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
3. Spherix Reports Second Quarter Earnings
4. Tapestry Reports Second Quarter 2007 Results
5. Callisto Reports on Second-Quarter 2007 Milestones
6. ImmuneRegen BioSciences Reports Material Transfer Agreement with VaxGen, Inc.
7. Vical Reports Second Quarter 2007 Financial Results, Allowance of Pandemic Influenza IND and Other Advances in Product Development Programs
8. Paper in International Journal of Oncology Reports Alfacells ONCONASE(R) Suppresses Intracellular Oxidative Stress
9. TAXUS WOMAN Study Reports Positive Clinical Outcomes for the TAXUS(R) Drug-eluting Stent in Women
10. Biopure Reports on Meeting with the FDA
11. Peregrine Reports Data Showing Bavituximabs Potential to Shrink Prostate Tumors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/15/2009)... what something looks like up close and personal? ASPEX ... Electron Microscope (PSEM), kicked off its "Send Us Your ... be scanned by one of their PSEMs. ... to 5mm and an imaging resolution of 25nm, capable ... ASPEX will not only scan your sample, but will ...
(Date:12/15/2009)... -- Cumberland Pharmaceuticals Inc. ( CPIX) ... results for a patient preference study evaluating Kristalose ... laxative packaged as a crystalline powder, compared to ... the only prescription-strength laxative available in pre-measured powder ... a recent diagnosis of chronic constipation were administered ...
(Date:12/15/2009)... Dec. 15 Fenwal Inc., a global ... separation, safety and availability, announced today that the ... approval to market InterSol ® platelet additive ... solution is a specialized product used in combination ... vital blood component used to prevent or treat ...
Breaking Medicine Technology:ASPEX Kicks Off Free 'Send Us Your Sample' Microscopy Campaign 2Kristalose(R) Preferred by Patients With Chronic Constipation Compared to Similar Products in a Recent Study 2Kristalose(R) Preferred by Patients With Chronic Constipation Compared to Similar Products in a Recent Study 3Fenwal Receives FDA Approval for New Solution Used to Store Donated Blood Platelets 2Center for Autism and Related Disorders Study Finds Hyperbaric Oxygen Therapy Ineffective Treatment for Children with Autism 61046 1Center for Autism and Related Disorders Study Finds Hyperbaric Oxygen Therapy Ineffective Treatment for Children with Autism 61046 2Trinity Health Selects Seven Elsevier Clinical Decision Support Solutions for its Multiple Facilities In Seven States 6120 1Trinity Health Selects Seven Elsevier Clinical Decision Support Solutions for its Multiple Facilities In Seven States 6120 2Trinity Health Selects Seven Elsevier Clinical Decision Support Solutions for its Multiple Facilities In Seven States 6120 3Trinity Health Selects Seven Elsevier Clinical Decision Support Solutions for its Multiple Facilities In Seven States 6120 4iSirona Selects New Chairman of the Board 14773 1iSirona Selects New Chairman of the Board 14773 2
(Date:12/16/2009)... proud to announce being presented with the Weatherhead 100 Upstart Award ... growing companies in Northeast Ohio and is a testament to hard ... , ... (PRWEB) December 16, 2009 -- Request A ... 100 Upstart Award on December 3, 2009. The Weatherhead 100 ...
(Date:12/16/2009)... to offer free nationwide confidential legal consultations for users of ... as: Birth Defects, Attempted Suicide, Suicide and Addiction Issues. Individuals ... 1-800-856-6405 or go to the firm’s website at http://www.ennislaw.com ... , ... (PRWEB) December 16, 2009 -- ...
(Date:12/15/2009)... researchers have successfully developed a new electrophoretic method ... the blood. The technique, using SARCOSYL-PAGE, has ... alter the performance characteristics of SDS-PAGE for detecting ... by a grant from the World Anti-Doping Agency ... Drug Testing and Analysis published by Wiley-Blackwell. ...
(Date:12/15/2009)... NAPA, Calif., Dec. 15 Senetek PLC (OTC Bulletin Board: SNKTY), a Life Sciences ... healthy aging, today announced that shareholders had approved all three resolutions that the Company had ... were as follows: , , Description of ... Votes ... For ...
(Date:12/15/2009)... Lupus Foundation of America and the Saint Thomas, Lupus ... Julian Lennon, son of the legendary John Lennon, and ... "LUCY," to raise funds for research on the disease ... of the proceeds from downloading "LUCY" at iTunes will ... and the Saint Thomas, Lupus Trust in Great Britain. ...
Breaking Medicine News(10 mins):Health News:Request A Test Receives Weatherhead 100 Upstart Award 2Health News:Ennis & Ennis, P.A. Announces Nationwide Free Legal Consultations For Users of Paxil 2Health News:Ennis & Ennis, P.A. Announces Nationwide Free Legal Consultations For Users of Paxil 3Health News:Researchers discover novel method for detecting MIRCERA 2Health News:Senetek PLC Announces 2009 Annual General Meeting Voting Results 2Health News:Senetek PLC Announces 2009 Annual General Meeting Voting Results 3Health News:Julian Lennon and James Scott Cook Release New Charity Single 'LUCY' to Raise Awareness and Funds for Lupus Research 2
... at Cornell University in Ithaca and Weill Cornell Medical ... of 23 protein biomarkers// in cerebrospinal fluid that acts ... to identify patients living with Alzheimer’s disease. ... of the journal Annals of Neurology. ,Right ...
... AIDS Control Programme (NACP) of India, has come up with ... transmission of HIV/AIDS" //is expected to cost Rs 342.81-crores. ... scheme. ,The fund will also be spent for ... and to provide HIV/AIDS care including antiretroviral therapy to those ...
... facial, dry fruit facial is the new entrant to skin ... dryness of the skin or other beauty related problems, dry ... for skin aliments. ,"This is a new technique and ... Dry fruit facial has benefited several of my clients. It ...
... to utilize original stem cells with the help// of an ... University's Robotics Institute and stem cell researchers from the University ... to organize the growth of stem cells into tissues. , ... team, spent time on mouse stem cells, which were taken ...
... fat in the diet with obesity, diabetes and cardiac ... such as asthma. ,News Limited newspapers reported that ... between fat consumed in a diet and immunity. ... the formation of asthma and other inflammatory diseases whose ...
... An alert has been issued by the Canadian Food Inspection Agency ... of fresh spinach, as they fear that it may be contaminated ... 284-gram packages and bears UPC 0 33383 65201 6 and Dec. ... off the shelves from the shops but the agency fears some ...
Other Medicine News:Health News:Protein ‘Fingerprint’ in Spinal Fluid Could Spot Alzheimer’s Dise 2Health News:Protein ‘Fingerprint’ in Spinal Fluid Could Spot Alzheimer’s Dise 3
... Used for temporary internal ... to the bladder. Supplied sterile ... one-time use. CAUTION: Periodic evaluation ... Sof-Flex stents must not remain ...
Used for stenting the urethra after hypospadias or epispadias repair and to provide post-operative drainage of the bladder. Supplied sterile in peel-open packages. Intended for one-time use....
... Used for catheter or instrument introduction. ... to be peeled away and removed. ... or instrument to be introduced should ... through the sheath. Supplied sterile in ...
Used to gain percutaneous access into the renal pelvis to treat stone disease. The dual lumen catheter and the Peel-Away® introducer are sized for use in pediatric patients. Supplied sterile in p...
Medicine Products: